Global Molecular Diagnostics For Std Market Size & Outlook

The global molecular diagnostics for std market size was estimated at USD 3,360.3 million in 2024 and is projected to reach USD 6,944.2 million by 2033, growing at a CAGR of 8.3% from 2025 to 2033.
Revenue, 2024 (US$M)
$3,360.3
Forecast, 2033 (US$M)
$6,944.2
CAGR, 2025 - 2033
8.3%
Report Coverage
Worldwide

Global molecular diagnostics for std market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Global molecular diagnostics for std market highlights

  • The global molecular diagnostics for std market generated a revenue of USD 3,360.3 million in 2024 and is expected to reach USD 6,944.2 million by 2033.
  • The market is expected to grow at a CAGR (2025 - 2033) of 8.3% by 2033.
  • In terms of segment, consumables (reagents and kits) accounted for a revenue of USD 2,539.6 million in 2024.
  • Softwares is the most lucrative product segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2024.
  • Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2033.

Global data book summary

Market revenue in 2024USD 3,360.3 million
Market revenue in 2033USD 6,944.2 million
Growth rate8.3% (CAGR from 2025 to 2033)
Largest segmentConsumables (reagents and kits)
Fastest growing segmentSoftwares
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationInstruments & Services, Consumables (Reagents and kits), Softwares

Other key industry trends

  • In terms of revenue, the North America accounted for 38.7% of the global molecular diagnostics for std market in 2024.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
  • By country, Mexico is the fastest growing regional market and is projected to reach USD 95.4 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Molecular Diagnostics For STD Market Companies

Name Profile # Employees HQ Website
F. Hoffmann-La Roche Ltd. View profile - - -
OraSure Technologies Inc View profile 638 220 East First Street, Bethlehem, PA, United States, 18015 https://www.orasure.com
Seegene View profile 51-100 Seoul, Seoul-t'ukpyolsi, South Korea, Asia http://www.seegene.com/
Diasorin SpA View profile 3233 Via Crescentino Snc, Saluggia, Vercelli, Italy, 13040 https://www.diasoringroup.com
BD View profile 10001+ Franklin Lakes, New Jersey, United States, North America https://www.bd.com
Hologic Inc View profile 6990 250 Campus Drive, Marlborough, MA, United States, 01752 http://www.hologic.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
BioMerieux SA View profile 13982 Marcy l’Etoile, Lyon, France, 69280 http://www.biomerieux.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

Global molecular diagnostics for std market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular diagnostics for std market will help companies and investors design strategic landscapes.


Consumables (reagents and kits) was the largest segment with a revenue share of 75.58% in 2024. Horizon Databook has segmented the Global molecular diagnostics for std market based on instruments & services, consumables (reagents and kits), softwares covering the revenue growth of each sub-segment from 2021 to 2033.


  • Global Molecular Diagnostics For STD Product Outlook (Revenue, USD Million, 2021-2033)
    • Instruments & Services
    • Consumables (Reagents and kits)
    • Softwares
  • Global Molecular Diagnostics For STD Application Outlook (Revenue, USD Million, 2021-2033)
    • CT/NG testing
    • Syphilis testing
    • Gonorrhea testing
    • HSV testing
    • HPV testing
    • HIV testing
    • Trichomonas
    • Ureaplasma + Mycoplasma
    • Other Application
  • Global Molecular Diagnostics For STD Technology Outlook (Revenue, USD Million, 2021-2033)
    • Laboratory Testing
      • Commercial/Private Labs
      • Public Health Labs
    • PoC testing

Reasons to subscribe to Global molecular diagnostics for std market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global molecular diagnostics for std market databook

  • Our clientele includes a mix of molecular diagnostics for std market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global molecular diagnostics for std market , including forecasts for subscribers. This global databook contains high-level insights into Global molecular diagnostics for std market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global molecular diagnostics for std market size, by regions, 2021-2033 (US$M)

Top 10 countries: Molecular diagnostics for std market size, 2024 (US$M)

Global molecular diagnostics for std market share, by product, 2024 & 2033 (%, US$M)

Molecular diagnostics for std market: Opportunity assessment by country

Global molecular diagnostics for std market, by region, 2024 (US$M)

Global molecular diagnostics for std market size, by regions, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online